Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City

被引：0
|
作者：
Daniel Lin
Judith D. Goldberg
Tsivia Hochman
Benjamin A. Levinson
Maria Khan
Elliot Newman
Lawrence P. Leichman
Heather T. Gold
机构：
[1] New York University School of Medicine,Division of Hematology & Medical Oncology, Department of Medicine
[2] New York University Langone Medical Center,Laura and Isaac Perlmutter Cancer Center
[3] New York University School of Medicine,Division of Biostatistics, Department of Population Health
[4] New York University School of Medicine,Division of Comparative Effectiveness and Decision Science, Department of Population Health
[5] New York University School of Medicine,Department of Surgery
[6] University of California San Diego,undefined
[7] Moores Cancer Center,undefined
来源：
Cancer Causes & Control | 2018年 / 29卷
关键词：
Colon cancer; Adjuvant chemotherapy; Timeliness; Outcomes; Healthcare delivery; Public hospitals;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 260
页数：7
相关论文
共 50 条
  • [31] Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
    Boakye, Daniel
    Jansen, Lina
    Halama, Niels
    Chang-Claude, Jenny
    Hoffmeister, Michael
    Brenner, Hermann
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [32] Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer
    Kumar, Aalok
    Peixoto, Renata D.
    Kennecke, Hagen F.
    Renouf, Daniel J.
    Lim, Howard J.
    Gil, Sharlene
    Speers, Caroline H.
    Cheung, Winson Y.
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 262 - 268
  • [33] THE BENEFIT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS AGED 75 OR OLDER WITH STAGE III COLON CANCER
    Chen, C. H.
    Yi-Jung, W.
    Lin, T. Y.
    [J]. VALUE IN HEALTH, 2019, 22 : S442 - S442
  • [34] Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused
    Becerra, Adan Z.
    Probst, Christian P.
    Tejani, Mohamedtalti A.
    Aquina, Christopher T.
    Gonzalez, Maynor G.
    Hensley, Bradley J.
    Noyes, Katia
    Monson, John R. T.
    Fleming, Fergal J.
    [J]. SURGERY, 2015, 158 (03) : 692 - 699
  • [35] Factors affecting time to adjuvant chemotherapy in stage III colon cancer patients.
    Holt, A.
    Nelson, R. A.
    Shibata, S.
    Lai, L. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Molecular characterization of stage III colon cancer patients with recurrence after adjuvant chemotherapy
    Franken, Ingrid
    Ketelaars, Steven
    Rubio-Alarcon, Carmen
    van Nassau, Sietske
    Schraa, Suzanna
    Meijer, Gerrit
    Sausen, Mark
    Koopman, Miriam
    Vink, Geraldine
    Abeln, Sanne
    Fijneman, Remond
    Roodhart, Jeanine
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [37] Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment
    Muss, Hyman B.
    Bynum, Debra L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2576 - 2578
  • [38] Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study
    van den Broek, C. B. M.
    Puylaert, C. C. E. M.
    Breugom, A. J.
    Bastiaannet, E.
    de Craen, A. J. M.
    van de Velde, C. J. H.
    Liefers, G. -J.
    Portielje, J. E. A.
    [J]. COLORECTAL DISEASE, 2017, 19 (10) : O358 - O364
  • [39] Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
    Jeong, Woon Kyung
    Shin, Je-Wook
    Baek, Seong Kyu
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2015, 89 (03) : 124 - 130
  • [40] Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer
    Daly, Meghan C.
    Hanseman, Dennis J.
    Abbott, Daniel E.
    Shah, Shimul A.
    Paquette, Ian M.
    [J]. DISEASES OF THE COLON & RECTUM, 2016, 59 (12) : 1134 - 1141
12345